Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
GLP-1 medications may also increase the risk of gallbladder disease, including gallstones and inflammation of the gallbladder
New York: Springer New York
branded options with your provider based on your insurance, budget, and clinical needs
Liraglutide Liraglutide (Victoza) was approved for use in T2D in 2009 by the EMA at doses of up to 1.8 mg once daily subcutaneous injection for people with T2D as monotherapy in those unable to take metformin or as add-on treatment to oral agents and/or insulin
While early findings suggest significant effects on weight, pain, inflammation, and joint tissues, main mechanisms and clinical implications remain unclear
US$ 21.22
US$ 28.70
US$ 24.31
US$ 23.99
US$ 28.34
US$ 21.89
